Neoadjuvant therapy with peptide receptor radionuclide therapy for pancreatic neuroendocrine tumours

被引:0
|
作者
Hallet, Julie [1 ,2 ]
Soreide, Kjetil [3 ,4 ,5 ]
机构
[1] Univ Toronto, Dept Surg, 2075 Bayview Ave,T2-102, Toronto, ON M4N 3M5, Canada
[2] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Div Surg Oncol, Susan Leslie Clin Neuroendocrine Tumours, Toronto, ON, Canada
[3] Stavanger Univ Hosp, Dept Gastrointestinal Surg, Stavanger, Norway
[4] Stavanger Univ Hosp, Lab Mol Med, Gastrointestinal Translat Res Grp, Stavanger, Norway
[5] Univ Bergen, Dept Clin Med, Bergen, Norway
关键词
D O I
10.1093/bjs/znae183
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Peptide Receptor Radionuclide Therapy (PRRT) as neoadjuvant therapy in neuroendocrine tumors - one center experience
    Opalinska, M.
    Sowa-Staszczak, A.
    Grochowska, A.
    Zwinczewska, H.
    Hubalewska-Dydejczyk, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S334 - S334
  • [32] Peptide receptor radionuclide therapy in non-neuroendocrine tumours - a field report
    Nilica, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S223 - S223
  • [33] Angiogenic biomarkers of response to treatment with peptide receptor radionuclide therapy in neuroendocrine tumours
    Strzelczyk, Janusz
    Wojcik-Giertuga, Monika
    Makulik, Karolina
    Rosiek, Violetta
    Kaminski, Grzegorz
    Kajdaniuk, Dariusz
    Kos-Kudla, Beata
    ENDOKRYNOLOGIA POLSKA, 2024, 75 (04) : 412 - 418
  • [34] Peptide receptor radionuclide therapy in entero-pancreatic neuroendocrine tumours: a multidisciplinary approach at the European Institute of Oncology
    Bodei, L.
    Baio, S. M.
    Fazio, N.
    Grana, C. M.
    Bonomo, G.
    Luca, F.
    Lorizzo, K.
    Ravizza, D.
    Gibelli, B.
    Monfardini, L.
    De Cicco, C.
    Pelosi, G.
    Arico, D.
    de Braud, F.
    Paganelli, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S350 - S350
  • [35] Neoadjuvant Downsizing by Internal Radiation A Case for Preoperative Peptide Receptor Radionuclide Therapy in Patients With Pancreatic Neuroendocrine Tumors
    Ezziddin, Samer
    Lauschke, Holger
    Schaefers, Michael
    Meyer, Carsten
    van Essen, Martijn
    Biersack, Hans-Juergen
    Kwekkeboom, Dik J.
    Ahmadzadehfar, Hojjat
    CLINICAL NUCLEAR MEDICINE, 2012, 37 (01) : 102 - 104
  • [36] Peptide receptor radionuclide therapy of neuroendocrine tumors
    Haug, A. R.
    Bartenstein, P.
    ONKOLOGE, 2011, 17 (07): : 602 - +
  • [37] Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors
    Bodei, Lisa
    Kidd, Mark
    Prasad, Vikas
    Modlin, Irvin M.
    NEUROENDOCRINE TUMORS: A MULTIDISCIPLINARY APPROACH, 2015, 44 : 198 - 215
  • [38] Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors
    Basu, Sandip
    Parghane, Rahul, V
    Kamaldeep
    Chakrabarty, Sudipta
    SEMINARS IN NUCLEAR MEDICINE, 2020, 50 (05) : 447 - 464
  • [39] Treatment guidelines for pancreatic neuroendocrine tumors (except peptide receptor radionuclide therapy)
    Duval, M.
    Vezzosi, D.
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2020, 24 (4-5): : 152 - 156
  • [40] MANAGEMENT OF RESIDUAL PAEDIATRIC PANCREATIC NEUROENDOCRINE TUMOUR WITH PEPTIDE RECEPTOR RADIONUCLIDE THERAPY
    Luthra, Tanvi
    Jain, Vishesh
    Dhua, Anjan
    Jana, Manisha
    Kandasamy, Devasenathipathy
    Kumar, Rakesh
    Shamim, Shamim
    Bal, C. S.
    Iyer, Venkateswaran
    Agarwala, Sandeep
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S64 - S65